Early Approval For Flonase Generic Puts Glaxo In A Bind

Law360, New York (February 24, 2006, 12:00 AM EST) -- A surprisingly early approval by U.S. regulators of a generic version of allergy treatment Flonase prompted GlaxoSmithKline Plc to rush to the courthouse this week, securing a restraining order that in effect also stopped shipments of its own authorized generic version.

Par Pharmaceutical Cos. abruptly halted its shipments of a generic version of Flonase after Glaxo Plc won a temporary restraining order against a generic version of the $900-million drug in a district court on Thursday.

The U.S. District Court for the District of Maryland granted...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.